Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (175 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio

by Zacks Equity Research

Stryker launches Steri-Shield 8, a cutting-edge PPE system with enhanced fit, visibility and protection, reinforcing its leadership in medical safety.

Zacks Equity Research

SYK Stock Gains on Launch of Hands-Free Device: Sync Badge

by Zacks Equity Research

Stryker's Sunc Badge is a Hands-free, wearable communication device that will support care team members with fast and reliable collaboration. It is likely to help offset the ongoing nurse shortage.

Mark Vickery headshot

Top Research Reports for Amazon, Eli Lilly & S&P Global

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Eli Lilly and Co. (LLY) and S&P Global Inc. (SPGI), as well as a micro-cap stock CVD Equipment Corporation (CVV).

Zacks Equity Research

PAHC or SYK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PAHC vs. SYK: Which Stock Is the Better Value Option?

Zacks Equity Research

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

by Zacks Equity Research

AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.

Urmimala Biswas headshot

4 Seniors & Aging Demographics Stocks to Watch Right Now

by Urmimala Biswas

ABBV, AMGN, SYK and DXCM are well-poised to benefit from the evolving new opportunities in Seniors & Aging Demographics within healthcare.

Indrajit Bandyopadhyay headshot

SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?

by Indrajit Bandyopadhyay

Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is the stock still a buy? Find out the key factors at play.

Indrajit Bandyopadhyay headshot

Will Cheaper AI Models Like DeepSeek Become a Boon? 3 Stocks to Watch

by Indrajit Bandyopadhyay

As costs related to AI models may come down, as is evident from the cheaper DeepSeek model from China, MedTech companies developing AI-based solutions like SYK, BSX and TEM are likely to gain.

Zacks Equity Research

Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business

by Zacks Equity Research

SYK announces agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC.

Zacks Equity Research

SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment Plans

by Zacks Equity Research

SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.